Evidence map›Paper›PMID 32486054›Full record

ArticleMolecules (Basel, Switzerland)2020

Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile.

Luisa M Deberle, Viviane J Tschan, Francesca Borgna, Fan Sozzi-Guo, Peter Bernhardt, Roger Schibli, Cristina Müller

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Tailored Reaction Conditions and Automated Radiolabeling of [International journal of molecular sciences · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. [Cancers · 2022
    Article
  9. Advances in PSMA theranostics.Translational oncology · 2022
    Article
  10. Review
  11. Preparation and Biological Evaluation of [Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Luisa M DeberleCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Viviane J TschanCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Francesca BorgnaCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Fan Sozzi-GuoCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Peter BernhardtDepartment of Radiation Physics, The Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.
Roger SchibliCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Cristina MüllerCenter for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen-PSI, Switzerland.
Paul Scherrer Institute · CHSahlgrenska University Hospital · SE

Funding

European Union's Horizon 2020 research and innovation program 701647Isotope Technologies Garchin ITG, Germany nonePersonalized Medicine and Related Technology (PHRT) program PHRT-301Swedish Cancer Society, Jubilee Clinic Cancer Research Foundation noneSwedish Research Council noneSwedish State ALF agreement noneSwiss Cancer Research Foundation KFS-4678-02-2019-R
6 · The paper itself

Abstract

The concept of using ibuprofen as an albumin-binding entity was recently demonstrated by the development of [

Indexed as

AlbuminsAnimalsAntigens, SurfaceBlood ProteinsCell Line, TumorChemistry Techniques, SyntheticFemaleGlutamate Carboxypeptidase IIKineticsLigandsLutetiumMaleMiceMice, Inbred BALB CProstatic NeoplasmsProtein BindingAlbuminsAntigens, SurfaceBlood ProteinsFOLH1 protein, humanGlutamate Carboxypeptidase IILigandsLutetiumLutetium-177RadioisotopesRadiopharmaceuticalsalbumin-binderibuprofenlinkerlutetium-177prostate cancerPSMA ligands

Identifiers

PMID32486054
PMCPMC7321364
OpenAlexW3029874672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.